Abstract
Acute odontogenic inflammatory diseases in the maxillofacial region, affecting 55-65% of cases, present a pressing issue in surgical dentistry. Despite extensive research, treatment outcomes remain suboptimal, with environmental factors and microbial etiology contributing to the challenge. A study from 2021 to 2023 examined 55 pediatric patients hospitalized for these conditions, emphasizing early diagnosis and surgical interventions. The addition of Abasit syrup to traditional treatments showcased promising results. The research underscores the need for meticulous surgical procedures and innovative therapeutic approaches.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
